Archive for January, 2011

Linda’s comments:  SAY TO to these scanners, they are dangerous.  Men need to think about prostate cancers.  Go for the pat down…

Link: http://www.blaylockreport.com/

Excerpt:

Dr. Blaylock: Body Scanners More Dangerous Than Feds Admit
Wednesday, November 24, 2010 9:58 AM
By Dr. Russell Blaylock
 
Dr. Russell Blaylock is a nationally recognized board-certified neurosurgeon, health practitioner, author, lecturer, and editor of The Blaylock Wellness Report. 
 
The growing outrage over the Transportation Security Administrations new policy of backscatter scanning of airline passengers and enhanced pat-downs brings to mind these wise words from President Ronald Reagan: The nine most terrifying words in the English language are: Im from the government and Im here to help you. 

So, what is all the concern really about – will these radiation scanners increase your risk of cancer or other diseases? A group of scientists and professors from the University of California at San Francisco voiced their concern to Obama’s science and technology adviser John Holdren in a well-stated letter back in April. 
The group included experts in radiation biology, biophysics, and imaging, who expressed serious concerns about the dangerously high dose of radiation to the skin. 

Radiation increases cancer risk by damaging the DNA and various components within the cells. Much of the damage is caused by high concentrations of free radicals generated by the radiation. Most scientists think that the most damaging radiation types are those that have high penetration, such as gamma-rays, but in fact, some of the most damaging radiation barely penetrates the skin. 

One of the main concerns is that most of the energy from the airport scanners is concentrated on the surface of the skin and a few millimeters into the skin. Some very radiation-sensitive tissues are close to the skin – such as the testes, eyes, and circulating blood cells in the skin. 

This is why defenders using such analogies as the dose being 1,000-times less than a chest X-ray and far less than what passengers are exposed to in-flight are deceptive. Radiation damage depends on the volume of tissue exposed. Chest X-rays and gamma-radiation from outer space is diffused over the entire body so that the dose to the skin is extremely small. Of note, outer space radiation does increase cancer rates in passengers, pilots, and flight attendants. 

Dr. Gordon’s Comments:

The Mumps vaccine failure rate is reported to be 77% so for almost no benefits they want to continue to expose children. Even proponents admit it is a process with DOCUMENTED RISKS, although they blame many of the risks on anything but vaccine side effects. The CDC lists the proven side effects.

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Link: http://www.naturalnews.com/028142_mumps_vaccines.html

Excerpt:

Mumps outbreak spreads among people who got vaccinated against mumps
Thursday, February 11, 2010
by Mike Adams, the Health Ranger
Editor of NaturalNews.com 

To hear the vaccine pushers say it, all the recent outbreaks of mumps and measles are caused by too few people seeking out vaccinations. It’s all those “non-vaccinated people” who are a danger to society, they say, because they can spread disease.

Reality tells a different story, however: It is the vaccinated people who are causing these outbreaks and spreading disease!

Just this week, an outbreak of mumps among more than 1,000 people in New Jersey and New York has raised alarm among infectious disease authorities. The outbreak itself is not unusual, though. What’s unusual is that the health authorities slipped up and admitted that most of the people infected with mumps had already been vaccinated against mumps.

In Ocean County, New Jersey, county spokeswoman Leslie Terjesen told CNN that 77 percent of those who caught mumps had already been vaccinated against mumps.
77 percent of those infected had been vaccinated
Usually this information is censored out of the press. The vaccine industry wants the public to believe that vaccines are effective at preventing infection. So the media typically refrains from reporting what percentage of the infected people were already vaccinated against the infectious disease.

But in this case, the 77 percent figure slipped out. And now intelligent observers are increasingly seeing the truth about these vaccines:

Who needs thyroid? That issue will be discussed by high level academicians who are lab experts who are discussing some new ways to evaluate thyroid function. Of course the book by Mark Starr MD called Hypothyroidism Type Two will not be on this agenda but these are some enlighten experts who see that current thyroid testing leaves much to be desired. 

Garry F. Gordon MD,DO,MD(H)
President, Gordon Research Institute
www.gordonresearch.com

Thyroid Testing Webinar

Contemporary Issues in Thyroid Disease Management
Wednesday, December 1, 2010
2:00–3:30pm Eastern U.S. Time

Register here: http://www.aacc.org/events/meetings/Pages/6201.aspx?

Approximately 20 million Americans now suffer from some form of thyroid disease, but experts estimate that about 13 million of them have not been diagnosed. With so many affected by a dysfunctional thyroid gland, thyroid function testing is becoming increasingly important to support both the diagnosis and management of thyroid disease. Unfortunately, controversy still exists concerning the upper limit of the TSH reference range and there is still confusion over when to use other thyroid immunoassays in the management of patients suspected of thyroid disease. Additionally, tandem mass spectrometry is rapidly emerging as a technology that could challenge labs’ reliance on traditional immunoassays for T4 and FT4. 

During this interactive webinar, you will hear the most up-to-date information on a variety of contemporary issues related to testing for thyroid disease. Our expert speakers will help you understand: 
•Where various organizations and interested parties now stand in the debate over the TSH upper reference limit 
•How to recognize and manage interferences in thyroid immunoassays 
•What’s new in testing for thyroid disease in pregnant women 
•When to use TT3, FT3, total T4, free T4, and thyroid autoantibody assays 
•Why one lab moved all of its FT4 testing to a tandem mass spec platform, and how it justifies the cost of using this technology 

Ask your questions online or via the phone during this must-attend, interactive webinar! 

The Experts: 
Laurence M. Demers, PhD, (moderator), Distinguished Professor of Pathology and Medicine, The Milton S. Hershey Medical Center at Penn State University, Hershey, PA
Steven J. Soldin, PhD, Professor in the Departments of Endocrinology and Metabolism and Pharmacology, Georgetown University, Washington, DC, and Clinical Director Endocrinology Laboratories NMS Laboratories, Willow Grove, PA
Carole A. Spencer, PhD, Professor of Medicine & Technical Director, Endocrine Services Laboratory, University of Southern California, Los Angeles, CA

Target Audience:
This program is designed for laboratorians, thyroid specialists, pathologists, laboratory directors, clinicians, endocrinologists, diagnostic manufacturers and anyone involved in the diagnosis or management of patients with thyroid disease.

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=211
92869&retmode=ref&cmd=prlinks

Excerpt:

We report 2 cases of babesiosis in immunocompetent patients in France. A
severe influenza-like disease developed in both patients 2 weeks after they
had been bitten by ticks. Diagnosis was obtained from blood smears, and
Babesia divergens was identified by PCR in 1 case.
**Babesiosis in Europe occurs in healthy patients, not only in
splenectomized patients**.

Excerpt:

“Q fever epidemic in the Chamonix valley” (France), is a recent headline from ProMed-mail.1 To date, 79 clinical cases have been identified with a further 22 seropositive individuals. This report has been followed by an outbreak affecting up to 86 people from Newport, South Wales.2 The causative organism, Coxiella burnetii has its reservoir in a broad range of vertebrates and arthropods.3 It is typically transmitted by the aerosol route, where it causes a zoonotic infection, but the source of this current outbreak remains elusive, as is often the case in retrospective epidemiological investigations.

Primary infection in human beings is symptomless in more than half of those infected.4,5 Signs of acute disease have no typical presentation, but tend to manifest as a self-limiting debilitating febrile illness for 2—14 days, non-typical pneumonia, or hepatitis.3 It is estimated that less than 5% of those with acute Q fever will develop chronic disease, the most common presentation of which is endocarditis. C burnetii accounts for 35% of all cases of infective endocarditis after infection with slow-growing or fastidious bacterial species (3% of total endocarditis cases), especially in those with prosthetic valves, previous valve injury, or rheumatic heart disease.6 Other cases are associated with immuno-suppression through corticosteroid use, cancer, AIDS, or lymphoma.6Manifestation of chronic disease may be delayed for several years possibly requiring C burnetii reactivation from a persistent latent form.

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21142958&retmode=ref&cmd=prlinks

Excerpt:

Abstract Thirty-two strains of Borrelia burgdorferi sensu lato were isolated
from Borrelia burgdorferi Sensu Lato collected from northeastern China from May to
June in 2004 and 2005. Restriction fragment length polymorphism (RFLP)
analysis and sequence analysis of 5S-23S rRNA intergenic spacer revealed
that 29 (90.6%) belonged to Borrelia garinii, demonstrating B, C, and a
unique pattern. The remaining three isolates (9.4%) were Borrelia afzelii
with pattern D. The phylogenetic analysis based on 5S-23S rRNA intergenic
spacer showed that B.
garinii and B. afzelii genospecies clustered into two separate lineages. B.
garinii strains were classified into three different branches: All the
strains with RFLP pattern C were in the same branch, strain VH10 with a
unique RFLP pattern clustered with strains VH9 and MDH2 with pattern B, and
the rest of the strains with pattern B constitute another branch. These
findings demonstrate the genetic diversity of B. burgdorferi sensu lato
isolates from northeastern China.

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21106294&retmode=ref&cmd=prlinks

Excerpt:

Tick-borne diseases are a constraint to livestock production in many
developing countries as they cause high morbidity and mortality, which
results in decreased production of meat, milk and other livestock
by-products. The most important tick-borne diseases of livestock in
sub-Saharan Africa are East Coast fever (caused by Theileria parva),
babesiosis (caused by Babesia bigemina and B.
bovis), anaplasmosis (caused by Anaplasma marginale) and heartwater (caused
by Ehrlichia ruminantium). Despite their economic importance, information on
the epidemiology of these diseases in many countries, including Zambia, is
often inadequate, making rational disease control strategies difficult to
implement.
In this study 18S and 16S rRNA gene PCR assays were used for a comprehensive
epidemiological analysis of tick-borne disease of cattle in three provinces
of Zambia (Lusaka, Central and Eastern). All the disease pathogens under
study (T.
parva, T. mutans, T. taurotragi, B. bovis, B. bigemina, Anaplasma spp and E.
ruminantium) were prevalent in each of the provinces surveyed. However,
variation was observed in prevalence between regions and seasons. There was
no association between live vaccination against East Coast fever and being
PCR positive for T. parva. A number of risk factors were shown to be
associated with
(a) the occurrence of tick-borne pathogens in cattle and (b) cattle tick
burdens in the wet season. A negative association was observed between the
number of co-infecting pathogens and the erythrocyte packed cell volume
(PCV) of carrier cattle. Crown Copyright (c) 2010. Published by Elsevier
B.V. All rights reserved

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21104602&retmode=ref&cmd=prlinks

Excerpt:

Members of the CURCUMA plant species (Zingiberaceae) have been used for
centuries in cooking, cosmetics, staining and in traditional medicine as
“omnipotent” remedies. Herbal preparations made with, and molecules
extracted from, CURCUMA have been shown to possess a wide variety of
pharmacological properties against malignant proliferation, hormonal
disorders, inflammation, and parasitosis among other conditions. This review
evaluates CURCUMA and its associated bioactive compounds, particularly
focusing on studies examining the parasiticidal activity of these components
against the tropical parasites PLASMODIUM, LEISHMANIA, TRYPANOSOMA,
SCHISTOSOMA and more generally against other cosmopolitan parasites
(nematodes, BABESIA, CANDIDA, GIARDIA, COCCIDIA and SARCOPTES). (c) Georg
Thieme Verlag KG Stuttgart . 
New York. 

Link: http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=21106777&retmode=ref&cmd=prlinks

Excerpt:

Several infectious agents may cause arthritis or arthropathy. For example,
infection with Borrelia burgdorferi, the etiologic agent of Lyme disease,
may in the late phase manifest as arthropathy. Infections with
Campylobacter, Salmonella or Yersinia may result in a postinfectious
reactive arthritis. Acute infection with parvovirus B19 (B19V) may likewise
initiate transient or chronic arthropathy. All these conditions may be
clinically indistinguishable from rheumatoid arthritis. Here, we present
evidence that acute B19V infection may elicit IgM antibodies that are
polyspecific or cross-reactive with a variety of bacterial antigens. Their
presence may lead to misdiagnosis and improper clinical management,
exemplified here by two case descriptions. Further, among
33 subjects with proven recent B19V infection we found IgM-enzyme immuno
assay
(EIA) positivity for Borrelia only, for Borrelia and Salmonella, for
Borrelia and Campylobacter, and for Borrelia, Campylobacer and Salmonella in
26 (78.7%),
1 (3%), 2 (6%), and 1 (3%), respectively, however, examined by Borrelia
LineBlot all samples were negative. These antibodies persisted over 3 months
in 4/13
(38%) patients tested. Likewise, in a retrospective comparison of the
results of a diagnostic laboratory, 9/11 (82%) patients with confirmed acute
B19V infection showed IgM to Borrelia. However, none of 12 patients with
confirmed borreliosis showed any serological evidence of acute B19V
infecion. Our study demonstrates that recent B19V infection can be
misinterpreted for secondary borreliosis or enteropathogen-induced reactive
arthritis. To perceive correct diagnosis we emphasize caution in
interpretation of polyreactive IgM and exclusion of recent B19V infection in
patients examined for infectious arthritis or arthropathy.